David Apelian

Dr. David Apelian is a Chief Executive Officer at Theolytics Ltd. and a Chief Executive Officer & Director at Eiger BioPharmaceuticals, Inc. He is on the Board of Directors at Eiger BioPharmaceuticals, Inc. Dr. Apelian was previously employed as a Chief Executive Officer & Director by BlueSphere Bio, Inc., a Chief Medical Officer & Executive Vice President by Achillion Pharmaceuticals, Inc., a Chief Medical Officer, SVP-Research & Development by GlobeImmune, Inc., a Clinical Director-Infectious Diseases Group by Bristol Myers Squibb Co., a Clinical Director-Hepatology Department by Schering-Plough Corp., and a Vice President by Wyeth Pharmaceuticals LLC.
He received his undergraduate degree from Rutgers State University of New Jersey, an MBA from Quinnipiac University, a doctorate degree from the University of Medicine & Dentistry of New Jersey and a doctorate degree from Rutgers State University of New Jersey.